John Cullity

Managing Director at BioSynergy Partners (New York based advisory spun out of Torreya). Chairman of Race Oncology (ASX listed).

At Torreya, John provided strategic advisory on Mergers & Acquisitions, Partnering and Financing and prior to Torreya, was a senior member of the Business Development team at Sanofi Pharmaceuticals, where he led buy-side transactions in oncology and diabetes. Earlier in his career, John was Head of Strategic Pricing & Reimbursement at Sanofi, Director of Health Economics at Schering-Plough, and Consultant at A.T. Kearney. He has also worked at The World Bank and the World Health Organization.

John graduated in Medicine and sub-specialised in haematology-oncology at QE II Medical Centre in Perth. He holds a Bachelor of Medicine, Bachelor of Surgery from The University of Western Australia; Membership in the Royal College of Physicians; Masters in Health Economics from London School of Economics & Political Science, and MBA from The Wharton School, University of Pennsylvania. John resides in New York.